{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:46:59Z","timestamp":1744174019233},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.thromres.2007.08.015","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T17:44:49Z","timestamp":1199900689000},"page":"69-76","source":"Crossref","is-referenced-by-count":11,"title":["On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression"],"prefix":"10.1016","volume":"122","author":[{"given":"Mario","family":"Menschikowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Hagelgans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lattke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iskander","family":"Ismailov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2007.08.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0968-0004(96)20031-3","article-title":"The growing phospholipase A2 superfamily of signal transduction enzymes","volume":"22","author":"Dennis","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.thromres.2007.08.015_bib2","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1074\/jbc.273.23.14411","article-title":"The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2","volume":"273","author":"Murakami","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2007.08.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2005.10.005","article-title":"Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?","volume":"79","author":"Menschikowski","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.thromres.2007.08.015_bib4","doi-asserted-by":"crossref","first-page":"23764","DOI":"10.1074\/jbc.273.37.23764","article-title":"Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa","volume":"273","author":"Mounier","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2007.08.015_bib5","first-page":"143","article-title":"Phospholipase A2 \u2014 a mediator between proximal and distal effectors of inflammation","volume":"12","author":"Vadas","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.thromres.2007.08.015_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01711354","article-title":"Prognostic value of serum phospholipase A in the multitraumatized patient","volume":"67","author":"Waydhas","year":"1989","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.thromres.2007.08.015_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.39.1.175","article-title":"Regulation and inhibition of phospholipase A2","volume":"39","author":"Balsinde","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.thromres.2007.08.015_bib8","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.2174\/092986705774462860","article-title":"Inhibitors of secretory phospholipase A2 group IIA","volume":"12","author":"Reid","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.thromres.2007.08.015_bib9","first-page":"417","article-title":"A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis","volume":"32","author":"Bradley","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.thromres.2007.08.015_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbalip.2006.08.003","article-title":"Control of phospholipase A2 activities for the treatment of inflammatory conditions","volume":"1761","author":"Yedgar","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2007.08.015_bib11","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlback","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.thromres.2007.08.015_bib12","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/00003246-200107001-00020","article-title":"Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis","volume":"29","author":"Grinnell","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.thromres.2007.08.015_bib13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/ajhp\/59.suppl_1.S19","article-title":"Recombinant human activated protein C in severe sepsis","volume":"59","author":"Mann","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.thromres.2007.08.015_bib14","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1186\/cc3747","article-title":"New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated)","volume":"9","author":"Macias","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2007.08.015_bib15","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2007.08.015_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0037-1613197","article-title":"Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-\u03b1 production by inhibiting activation of both nuclear factor-\u03baB and activator protein-1 in human monocytes","volume":"88","author":"Yuksel","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2007.08.015_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00011-004-1291-z","article-title":"Drotrecogin alfa (activated) inhibits NF-\u03baB activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis","volume":"53","author":"Brueckmann","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.thromres.2007.08.015_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1388-1981(00)00117-7","article-title":"Transcriptional regulation of inflammatory secreted phospholipases A2","volume":"1488","author":"Andreani","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2007.08.015_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0014-5793(95)00402-U","article-title":"Pyrrolidine dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group II phospholipase A2 in rat renal mesangial cells","volume":"364","author":"Walker","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.thromres.2007.08.015_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bj20020658","article-title":"Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1\u03b2 in vascular smooth muscle cells: interplay of the CCAAT\/enhancer binding protein (C\/EBP), nuclear factor-\u03baB and Ets transcription factors","volume":"368","author":"Antonio","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.thromres.2007.08.015_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbalip.2005.01.001","article-title":"Statins potentiate the IFN-\u03b3 induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells","volume":"1733","author":"Menschikowski","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2007.08.015_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2002-12-3880","article-title":"Expression and function of the endothelial protein C receptor in human neutrophils","volume":"102","author":"Sturn","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2007.08.015_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/0264-6021:3500717","article-title":"A new phosphospecific cell-based ELISA for p42\/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein","volume":"350","author":"Versteeg","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.thromres.2007.08.015_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/bbrc.1998.9188","article-title":"Transforming growth factor-\u03b21-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism","volume":"249","author":"Axmann","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.thromres.2007.08.015_bib25","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0006-2952(99)00279-8","article-title":"Modulation of cytokine-induced expression of secretory phospholipase A2-type IIA by protein kinase C in rat renal mesangial cells","volume":"58","author":"Scholz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.thromres.2007.08.015_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.RES.0000133680.87668.FA","article-title":"Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo","volume":"95","author":"Uchiba","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2007.08.015_bib27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.0022-202X.2005.23952.x","article-title":"Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C","volume":"125","author":"Xue","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.thromres.2007.08.015_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.RES.0000255685.06922.c7","article-title":"Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor","volume":"100","author":"Bretschneider","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2007.08.015_bib29","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.thromres.2007.08.015_bib30","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.bjp.0703947","article-title":"Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells","volume":"132","author":"Bretschneider","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.thromres.2007.08.015_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00916098","article-title":"Antiinflammatory action of thielocin A1\u03b2, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy","volume":"17","author":"Tanaka","year":"1993","journal-title":"Inflammation"},{"key":"10.1016\/j.thromres.2007.08.015_bib32","first-page":"807","article-title":"The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2","volume":"134","author":"Vadas","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.thromres.2007.08.015_bib33","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/01.CCM.0000171540.54520.69","article-title":"LY315920NA\/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis","volume":"33","author":"Zeiher","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.thromres.2007.08.015_bib34","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1074\/jbc.M109699200","article-title":"Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2","volume":"277","author":"Koduri","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384807003349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384807003349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T15:00:31Z","timestamp":1557154831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384807003349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0049384807003349"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2007.08.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}